| SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ... Nature communications 11 (1), 5064, 2020 | 347 | 2020 |
| Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality—brief report A Rosell, S Havervall, F von Meijenfeldt, Y Hisada, K Aguilera, SP Grover, ... Arteriosclerosis, Thrombosis, and Vascular Biology 41 (2), 878-882, 2021 | 201 | 2021 |
| Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19 H Ng, S Havervall, A Rosell, K Aguilera, K Parv, FA von Meijenfeldt, ... Arteriosclerosis, thrombosis, and vascular biology 41 (2), 988-994, 2021 | 191 | 2021 |
| Quantification of citrullinated histones: Development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma C Thålin, K Aguilera, NW Hall, MR Marunde, JM Burg, A Rosell, ... Journal of Thrombosis and Haemostasis 18 (10), 2732-2743, 2020 | 66 | 2020 |
| Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19 S Havervall, H Ng, A Jernbom Falk, N Greilert‐Norin, A Månberg, ... Journal of internal medicine 291 (1), 72-80, 2022 | 64 | 2022 |
| 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection U Marking, O Bladh, S Havervall, J Svensson, N Greilert-Norin, K Aguilera, ... The Lancet Infectious Diseases 23 (2), 150-152, 2023 | 52 | 2023 |
| Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer A Rosell, K Aguilera, Y Hisada, C Schmedes, N Mackman, H Wallén, ... Scientific reports 11 (1), 5074, 2021 | 39 | 2021 |
| Humoral immune responses to the monovalent XBB. 1.5-adapted BNT162b2 mRNA booster in Sweden U Marking, O Bladh, K Aguilera, Y Yang, NG Norin, K Blom, S Hober, ... The Lancet Infectious Diseases 24 (2), e80-e81, 2024 | 22 | 2024 |
| Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose O Bladh, U Marking, S Havervall, NG Norin, K Aguilera, S Hober, ... The Lancet. Microbe, 2023 | 21 | 2023 |
| The expression of microvesicles in the blood of patients with G raves' disease and its relationship to treatment F Mobarrez, M Abraham‐Nordling, K Aguilera‐Gatica, I Friberg, A Antovic, ... Clinical Endocrinology 84 (5), 729-735, 2016 | 17 | 2016 |
| Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts P Smith, A Rosell, M Farm, M Bruzelius, K Aguilera Gatica, N Mackman, ... Plos one 17 (7), e0270865, 2022 | 13 | 2022 |
| SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun 2020; 11: 5064 AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ... | 13 | |
| Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum O Bladh, K Aguilera, U Marking, M Kihlgren, N Greilert Norin, ... Frontiers in Immunology 15, 1346749, 2024 | 10 | 2024 |
| SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020; 11 (1): 5064 AS Rudberg, S Havervall, A Månberg, A Jernbom Falk, K Aguilera, H Ng, ... Epub 2020/10/10. https://doi. org/10.1038/s41467-020-18848-0 PMID: 33033249, 0 | 10 | |
| Response by Mackman et al to Letter Regarding Article,“Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is … N Mackman, Y Hisada, SP Grover, A Rosell, S Havervall, ... Arteriosclerosis, Thrombosis, and Vascular Biology 41 (6), e381-e382, 2021 | 8 | 2021 |
| Mucosal and serum antibodies 3 weeks after symptomatic BA. 2.86 infection O Bladh, N Greilert-Norin, S Havervall, U Marking, K Aguilera, JJ Alm, ... New England Journal of Medicine 389 (17), 1626-1628, 2023 | 3 | 2023 |
| Humoral immune responses to the monovalent XBB. 1.5-adapted BNT162b2 mRNA booster U Marking, O Bladh, K Aguilera, Y Yang, NG Norin, K Blom, S Hober, ... BioRxiv, 2023.12. 21.572575, 2023 | 2 | 2023 |
| Neutralisation sensitivity of the SARS-CoV-2 BA. 2.87. 1 variant DJ Sheward, U Marking, O Bladh, S Held, E Looyens, L Vandenabeele, ... bioRxiv, 2024.03. 21.586176, 2024 | 1 | 2024 |
| Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023 K Aguilera, O Bladh, U Marking, NG Norin, A Rihani, D Ujvari, FC Ning, ... The Lancet Regional Health–Europe 38, 2024 | 1 | 2024 |
| PO-105 Quantification of citrullinated histones in human blood samples: challenges and development of a nucleosome-based assay to quantify H3Cit-DNA in human plasma A Thålin, K Aguilera, NW Hall, MR Marunde, JM Burg, A Rosell, ... Thrombosis Research 200, S77, 2021 | | 2021 |
